Zika ELITe MGB® Kit U.S. nominated for Best New Clinical Product of 2016!

Nominated! Zika ELITe MGB® Kit U.S.



Each year the SelectScience® Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry.

This year, ELITechGroup’s EUA assay Zika ELITe MGB® Kit U.S. has been nominated for “Best New Clinical Product of 2016”. This cost-effective, high-performing Real-Time PCR assay, in combination with ELITe InGenius®, offers unique benefits in terms of ease-of-use and time-to-result in comparison to other Emergency Use Authorization assays.


Learn more about ELITe InGenius and Zika ELITe MGB Kit U.S. by: 




Zika ELITe MGB® Kit U.S.:

  • This test has not been FDA cleared or approved;
  • This test has been authorized by FDA under an EUA for use by authorized laboratories;
  • This test has been authorized only for the detection of RNA from Zika virus and diagnosis of Zika virus infection, not for any other viruses or pathogens;
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

M500985 r0

Leave a Reply

  • (will not be published)